Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Distinct Phenotypes of Shank2 Mouse Models Reflect Neuropsychiatric Spectrum Disorders of Human Patients With SHANK2 Variants.

Eltokhi A, Rappold G, Sprengel R.

Front Mol Neurosci. 2018 Jul 19;11:240. doi: 10.3389/fnmol.2018.00240. eCollection 2018. Review.

2.

USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels.

Kerrisk Campbell M, Sheng M.

J Neurosci. 2018 Jun 6;38(23):5289-5301. doi: 10.1523/JNEUROSCI.3305-17.2018. Epub 2018 May 7.

PMID:
29735556
3.

A direct regulatory link between microRNA-137 and SHANK2: implications for neuropsychiatric disorders.

de Sena Cortabitarte A, Berkel S, Cristian FB, Fischer C, Rappold GA.

J Neurodev Disord. 2018 Apr 17;10(1):15. doi: 10.1186/s11689-018-9233-1.

4.
5.

Structural basis for PDZ domain interactions in the post-synaptic density scaffolding protein Shank3.

Ponna SK, Ruskamo S, Myllykoski M, Keller C, Boeckers TM, Kursula P.

J Neurochem. 2018 Jun;145(6):449-463. doi: 10.1111/jnc.14322. Epub 2018 Jun 10.

PMID:
29473168
6.

Deficits in the Proline-Rich Synapse-Associated Shank3 Protein in Multiple Neuropsychiatric Disorders.

Alexandrov PN, Zhao Y, Jaber V, Cong L, Lukiw WJ.

Front Neurol. 2017 Dec 11;8:670. doi: 10.3389/fneur.2017.00670. eCollection 2017.

7.

Characterization of the zinc-induced Shank3 interactome of mouse synaptosome.

Lee Y, Ryu JR, Kang H, Kim Y, Kim S, Zhang Y, Jin C, Cho HM, Kim WK, Sun W, Han K.

Biochem Biophys Res Commun. 2017 Dec 16;494(3-4):581-586. doi: 10.1016/j.bbrc.2017.10.143. Epub 2017 Oct 28.

PMID:
29111324
8.

Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases.

Sundararajan T, Manzardo AM, Butler MG.

Gene. 2018 Jan 30;641:25-34. doi: 10.1016/j.gene.2017.10.035. Epub 2017 Oct 13.

PMID:
29032150
9.

Integrative Analysis of Brain Region-specific Shank3 Interactomes for Understanding the Heterogeneity of Neuronal Pathophysiology Related to SHANK3 Mutations.

Lee Y, Kang H, Lee B, Zhang Y, Kim Y, Kim S, Kim WK, Han K.

Front Mol Neurosci. 2017 Apr 19;10:110. doi: 10.3389/fnmol.2017.00110. eCollection 2017.

10.

Investigation of SHANK3 in schizophrenia.

de Sena Cortabitarte A, Degenhardt F, Strohmaier J, Lang M, Weiss B, Roeth R, Giegling I, Heilmann-Heimbach S, Hofmann A, Rujescu D, Fischer C, Rietschel M, Nöthen MM, Rappold GA, Berkel S.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):390-398. doi: 10.1002/ajmg.b.32528. Epub 2017 Mar 28.

PMID:
28371232
11.

[Epigenetics' implication in autism spectrum disorders: A review].

Hamza M, Halayem S, Mrad R, Bourgou S, Charfi F, Belhadj A.

Encephale. 2017 Aug;43(4):374-381. doi: 10.1016/j.encep.2016.07.007. Epub 2016 Sep 28. Review. French.

PMID:
27692350
12.

Shank3 Is Part of a Zinc-Sensitive Signaling System That Regulates Excitatory Synaptic Strength.

Arons MH, Lee K, Thynne CJ, Kim SA, Schob C, Kindler S, Montgomery JM, Garner CC.

J Neurosci. 2016 Aug 31;36(35):9124-34. doi: 10.1523/JNEUROSCI.0116-16.2016.

13.

Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.

Li J, Wilkinson B, Clementel VA, Hou J, O'Dell TJ, Coba MP.

Sci Signal. 2016 Aug 9;9(440):rs8. doi: 10.1126/scisignal.aaf6716.

PMID:
27507650
14.

Receptor Tyrosine Kinase MET Interactome and Neurodevelopmental Disorder Partners at the Developing Synapse.

Xie Z, Li J, Baker J, Eagleson KL, Coba MP, Levitt P.

Biol Psychiatry. 2016 Dec 15;80(12):933-942. doi: 10.1016/j.biopsych.2016.02.022. Epub 2016 Feb 26.

15.

Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects.

Zhou Y, Kaiser T, Monteiro P, Zhang X, Van der Goes MS, Wang D, Barak B, Zeng M, Li C, Lu C, Wells M, Amaya A, Nguyen S, Lewis M, Sanjana N, Zhou Y, Zhang M, Zhang F, Fu Z, Feng G.

Neuron. 2016 Jan 6;89(1):147-62. doi: 10.1016/j.neuron.2015.11.023. Epub 2015 Dec 10.

16.

Micro-electrode array recordings reveal reductions in both excitation and inhibition in cultured cortical neuron networks lacking Shank3.

Lu C, Chen Q, Zhou T, Bozic D, Fu Z, Pan JQ, Feng G.

Mol Psychiatry. 2016 Feb;21(2):159-68. doi: 10.1038/mp.2015.173. Epub 2015 Nov 24.

PMID:
26598066
17.

Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disorders.

Choi SY, Pang K, Kim JY, Ryu JR, Kang H, Liu Z, Kim WK, Sun W, Kim H, Han K.

Mol Brain. 2015 Nov 16;8(1):74. doi: 10.1186/s13041-015-0165-3.

18.

Mutation burden of rare variants in schizophrenia candidate genes.

Girard SL, Dion PA, Bourassa CV, Geoffroy S, Lachance-Touchette P, Barhdadi A, Langlois M, Joober R, Krebs MO, Dubé MP, Rouleau GA.

PLoS One. 2015 Jun 3;10(6):e0128988. doi: 10.1371/journal.pone.0128988. eCollection 2015.

19.

Translational neurobiology in Shank mutant mice--model systems for neuropsychiatric disorders.

Schmeisser MJ.

Ann Anat. 2015 Jul;200:115-7. doi: 10.1016/j.aanat.2015.03.006. Epub 2015 Apr 13. Review.

PMID:
25917711
20.

MicroRNA-7/Shank3 axis involved in schizophrenia pathogenesis.

Zhang J, Sun XY, Zhang LY.

J Clin Neurosci. 2015 Aug;22(8):1254-7. doi: 10.1016/j.jocn.2015.01.031. Epub 2015 Apr 14.

PMID:
25882257

Supplemental Content

Loading ...
Support Center